Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05020028 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

StatusRecruiting
PhasePhase 2/3
Started2022-06-22
View on ClinicalTrials.gov ↗

Amendment history

2026-06-05
Study Status, Contacts/Locations v7
Primary completion date2026-09→2027-09
Completion date2026-09→2027-09
2025-07-31
Study Status, Contacts/Locations v6
Primary completion date2025-09→2026-09
Completion date2025-09→2026-09
2024-09-13
Study Status v5
Primary completion date2024-06→2025-09
Completion date2024-06→2025-09
2024-04-01
Study Status v4
Re-verified, no change to tracked fields
2023-05-22
Study Status v3
Primary completion date2023-06→2024-06
Completion date2023-06→2024-06
Show 2 earlier versions
2022-07-15
Study Status, Sponsor/Collaborators, Study Description, Arms and Interventions, Outcome Measures v2
Secondary endpoints1 to 12 entries
ChangeKnee inInjury patientand satisfactionOsteoarthritis Outcome Score (KOOS) Knee Injury and Osteoarthritis Outcome Score (KOOS) Knee Injury and Osteoarthritis Outcome Score (KOOS) Knee Injury and Osteoarthritis Outcome Score (KOOS) VAS Satisfaction with Pain Management Score VAS Satisfaction with Pain Management Score VAS Satisfaction wit [...]
Primary endpoints1 to 7 entries
ChangeVAS inPain painSeverity perceptionScore VAS Pain Severity Score VAS Pain Severity Score VAS Pain Severity Score VAS Pain Severity Score VAS Pain Severity Score VAS Pain Severity Score
Study description+4 characters
[...] atients will be asked on treatment Day 1, 2, 7, and 14, 28, 42, and 4284 to rate their pain according to the VAS scale. Additionally [...]
Collaborators+11 characters
Orcosa Inc.
2022-06-28
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-06→confirmed 2022-06-22
Study sites0→1
2021-08-20
Original filing
The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can lessen pain, improve function, and improve patient satisfaction in cases of knee osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not produce a 'high' or altered mental state) as compared to tetrahydrocannabinol (THC), another compound found in cannabis. Researchers are studying different forms of CBD for potential use in treating pain, inflammation, and illnesses.
Trial Details
NCT Number NCT05020028
Lead Sponsor NYU Langone Health
Collaborators: Orcosa Inc.
Conditions Knee Arthritis
Enrollment 100 participants
Start Date 2022-06-22
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-09